References

VESIsorb® Evidence for Rapid and Maximum BCP Absorption

Clinical Evidence: VESIsorb® is a safe and effective drug delivery pharmaceutical technology that can help  dramatically improve the bioavailability of poorly absorbed ingredients such as THC, CBD and terpenes (BCP). A specific clinical trial (among many trials conducted for VESIsorb® products) tested for improvement in BCP absorption and showed a 3.6 x increase in absorption (Cmax) and 2x faster (Tmax) than comparable CBD products without VESIsorb®. 

Clinical and Scientific Evidence References: 

Modinger, Yvonne et al, Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS) Molecules 2022, 27(9), 2860; 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104399

VESIsorb® Evidence for Rapid and Maximum CBD Absorption

Versafilm® Evidence for Enhanced Sublingual Absorption

THC Evidence for Pain and Related Syndromes

CBD, Rosemary Oil and Tea Tree Oil Scientific Evidence as Antibacterial and Anti-acne

CBD and CBDA Evidence for Nausea and Vomiting

CBD Evidence for Psoriasis and Eczema

CBD Evidence for Pain and Inflammation

CBD Evidence for Localized Pain and Inflammation

CBD Evidence for Anxiety and PTSD